| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/12/2013 | US8394929 Nogo receptor-mediated blockade of axonal growth |
| 03/12/2013 | US8394924 Directed engagement of activating Fc receptors |
| 03/12/2013 | US8394777 Treating immunodeficiencies by intrathymic injection of nucleotide sequences |
| 03/12/2013 | US8394771 Multimeric proteins and methods of making and using same |
| 03/12/2013 | US8394770 Vm23 and Vm24, two scorpion peptides that block human T-lymphocyte potassium channels (sub-type Kv1.3) with high selectivity and decrease the in vivo DTH-responses in rats |
| 03/12/2013 | US8394768 Synergistic therapeutic use of Prothrombin Complex Concentrates with FVIII concentrates |
| 03/12/2013 | US8394764 Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use |
| 03/12/2013 | US8394763 Cyclic undecapeptides and derivatives as multiple sclerosis therapies |
| 03/12/2013 | US8394760 Multifunctional nanostructures, methods of synthesizing thereof, and methods of use thereof |
| 03/12/2013 | US8394758 Tumor-targeting peptides and uses thereof |
| 03/12/2013 | US8394756 Methods of increasing RDCVF 1 or RDCVF 2 polypeptides in retinal cells |
| 03/12/2013 | US8394634 Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding LNT2 polypeptides and homologs thereof |
| 03/12/2013 | US8394605 Genetically programmed expression of proteins containing the unnatural amino acid phenylselenocysteine |
| 03/12/2013 | US8394603 Codon-optimized nucleic acid for coding apo-clytin-II and method for using the same |
| 03/12/2013 | US8394589 Methods for diagnosing scapuloperoneal spinal muscular atrophy or Charcot-Marie-Tooth disease type 2C by detecting mutations in TRPV4 |
| 03/12/2013 | US8394390 Neisserial antigenic peptides |
| 03/12/2013 | US8394387 Recombinant modified Bacillus anthracis protective antigen for use in vaccines |
| 03/12/2013 | US8394375 Antibodies for amyloid specific peptides |
| 03/12/2013 | CA2521174C Enhanced hiv-1 vaccines and methods for their use |
| 03/12/2013 | CA2509345C Bacterial cell component-unresponsive model mouse |
| 03/12/2013 | CA2480199C Fp-ghrelin |
| 03/12/2013 | CA2468888C Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof |
| 03/12/2013 | CA2464092C Electroprocessing in drug delivery and cell encapsulation |
| 03/12/2013 | CA2454421C Use of long pentraxin ptx3 for treating female infertility |
| 03/12/2013 | CA2453561C Use of the disintegrin domain of an adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent |
| 03/12/2013 | CA2407910C Antibodies that immunospecifically bind to blys |
| 03/12/2013 | CA2369908C Protein/polypeptide-k obtained from momordica charantia and a process for the extraction thereof |
| 03/12/2013 | CA2354599C Binding molecules for human factor viii and factor viii-like proteins |
| 03/12/2013 | CA2295552C Cloned genomes of infectious hepatitis c viruses and uses thereof |
| 03/12/2013 | CA2288218C Novel differentiation-inhibitor |
| 03/07/2013 | WO2013033675A1 Chimeric natriuretic peptide compositions and methods of preparation |
| 03/07/2013 | WO2013033561A1 Vegf-specific capture agents, compositions and methods of using and making |
| 03/07/2013 | WO2013033518A1 Methods for treating properdin-related diseases or disorders |
| 03/07/2013 | WO2013033456A2 Microbial nanowires and methods of making and using |
| 03/07/2013 | WO2013033363A1 Mycobacterium tuberculosis porins and toxins and related methods |
| 03/07/2013 | WO2013033260A1 Use of hdl-related molecules to treat and prevent proinflammatory conditions |
| 03/07/2013 | WO2013032999A2 Polydnavirus delivery constructs |
| 03/07/2013 | WO2013032879A1 Targeting podoplanin with lectin for use in the prevention and treatment of cancer |
| 03/07/2013 | WO2013032784A1 Natriuretic polypeptides |
| 03/07/2013 | WO2013032012A1 Glycosylated polypeptide and drug composition containing said polypeptide |
| 03/07/2013 | WO2013032011A1 Glycosylated polypeptide and drug composition containing said polypeptide |
| 03/07/2013 | WO2013031882A1 Vaccine preparation for cancer treatment |
| 03/07/2013 | WO2013031833A1 Skin introduction system and lightening agent combining cell introduction peptide and skin introduction accelerator |
| 03/07/2013 | WO2013031827A1 Rsv mucosal vaccine |
| 03/07/2013 | WO2013030785A1 Biomarkers for lysosomal storage disorders |
| 03/07/2013 | WO2013030783A1 Immunogenic proteins and compositions |
| 03/07/2013 | WO2013030678A2 Modified toll-like receptor 2 (tlr2) ligands as inhibitors of neutrophil recruitment |
| 03/07/2013 | WO2013030620A2 Gene encoded for an mhc class i molecule, plasmid, expression system protein, multimer, reagent and kit for analyzing a t cell frequency |
| 03/07/2013 | WO2013030608A1 Nanoparticle-based veterinary vaccine |
| 03/07/2013 | WO2013030569A2 Peptides |
| 03/07/2013 | WO2013030329A1 Protein expression |
| 03/07/2013 | WO2013030320A1 Synthetic capsid proteins and uses thereof |
| 03/07/2013 | WO2013030310A1 Detection of prame gene expression in cancer |
| 03/07/2013 | WO2013030302A1 Protein complex comprising mcm8 and mcm9 proteins and their use |
| 03/07/2013 | WO2013030165A1 Multi-strain-reactive antibodies for therapy and diagnosis of influenza |
| 03/07/2013 | WO2013029496A1 Polypeptides having glucoamylase activity and polynucleotides encoding same |
| 03/07/2013 | WO2013029494A1 Polypeptides having glucoamylase activity and polynucleotides encoding same |
| 03/07/2013 | WO2013029279A1 Novel glp-i analogue, preparation method and use thereof |
| 03/07/2013 | WO2013029205A1 Cleavable protein of interferon fused with human serum albumin and encoding gene and use thereof |
| 03/07/2013 | WO2013009627A3 Factor viii chimeric and hybrid polypeptides, and methods of use thereof |
| 03/07/2013 | WO2013007704A3 Novel sdf-1-based glycosaminoglycan antagonist and methods of using same |
| 03/07/2013 | WO2012174430A3 Methods of making nylon intermediates from glycerol |
| 03/07/2013 | WO2012172347A9 Diagnosing and treating inflammatory bowel disease and irritable bowel syndrome |
| 03/07/2013 | WO2012172345A3 Treating conditions associated with allergy |
| 03/07/2013 | WO2012172343A3 Treating primary sclerosing cholangitis |
| 03/07/2013 | WO2012172342A3 Treating multiple sclerosis |
| 03/07/2013 | WO2012172340A3 Treating mental disorders |
| 03/07/2013 | WO2012172339A3 Treating inflammatory arthritis |
| 03/07/2013 | WO2012172337A3 Treating cardiovascular disease |
| 03/07/2013 | WO2012172336A3 Treating inflammatory skin diseases |
| 03/07/2013 | WO2012160333A3 Recombinant yeast expressing human h- ferritin |
| 03/07/2013 | WO2012140274A9 Agonists and antagonists of the wnt pathway |
| 03/07/2013 | WO2012127464A3 Constitutively activated t cells for use in adoptive cell therapy |
| 03/07/2013 | WO2012062873A3 Highly immunogenic hiv p24 sequences |
| 03/07/2013 | WO2012032287A9 Gene regulation by dna methylation |
| 03/07/2013 | WO2011156331A9 Human neural progenitor derived dopaminergic progenitors and neurons |
| 03/07/2013 | US20130061352 Plant Defense Signal Peptides |
| 03/07/2013 | US20130061351 Method for producing recombinant proteins from plant hairy roots |
| 03/07/2013 | US20130061348 Nucleic Acid Sequences Encoding Proteins Associated with Abiotic Stress Responses and Plant Cells with Increased Tolerance to Environmental Stress |
| 03/07/2013 | US20130061346 Insect resistant and herbicide tolerant soybean event 9582.814.19.1 |
| 03/07/2013 | US20130060012 Method for purifying bone morphogenetic protein |
| 03/07/2013 | US20130060008 Method for silk fibroin gelation using sonication |
| 03/07/2013 | US20130060003 Chemical preparation of polyubiquitin chains |
| 03/07/2013 | US20130059928 Method for preparing alkaline hydrolysates of plant proteins |
| 03/07/2013 | US20130059798 Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway |
| 03/07/2013 | US20130059793 Egf receptor mimicking peptides |
| 03/07/2013 | US20130059785 Gene and Polypeptide Sequences |
| 03/07/2013 | US20130059781 Long-Acting Gastrin Derivatives |
| 03/07/2013 | US20130059780 Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1] |
| 03/07/2013 | US20130059776 Antiviral Cell-Penetrating Peptides |
| 03/07/2013 | US20130059773 Compounds for the treatment of inflammation and neutropenia |
| 03/07/2013 | US20130059770 Polypeptides |
| 03/07/2013 | US20130059757 Novel Gene Targets Associated with Amyotrophic Lateral Sclerosis and Methods of Use Thereof |
| 03/07/2013 | US20130059752 Compositions and methods for the treatment of immune related diseases |
| 03/07/2013 | US20130059732 Aav capsid proteins for nucleic acid transfer |
| 03/07/2013 | US20130059380 Preservation solutions for biologics and methods related thereto |
| 03/07/2013 | US20130059332 Method for the production of an aqueous glucose solution |
| 03/07/2013 | US20130059312 Methods Of Using Chimeric Receptors to Identify Autoimmune Disease |
| 03/07/2013 | US20130059299 Aberrant mitochondrial dna, associated fusion transcripts and translation products and hybridization probes therefore |
| 03/07/2013 | US20130059289 Adeno-associated virus serotype i nucleic acid sequences, vectors and host cells containing same |